Variant report

Variant	nsv551845
Chromosome Location	chr10:90919135-90964026
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:90807595..90810361-chr10:90944518..90946449,2	MCF-7	breast:

Extended variants
information (count: 1269 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:1269 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs12261436	chr10:90919135-90919136	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs150463748	chr10:90919141-90919142	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs137981603	chr10:90919148-90919149	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs544328229	chr10:90919155-90919156	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs149494896	chr10:90919162-90919163	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs578174786	chr10:90919202-90919203	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs143956803	chr10:90919300-90919301	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs544982359	chr10:90919394-90919395	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs114649965	chr10:90919411-90919412	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs139787669	chr10:90919496-90919497	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs540908518	chr10:90919527-90919528	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs562344249	chr10:90919543-90919544	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs529433335	chr10:90919566-90919567	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs551077383	chr10:90919581-90919582	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs569206261	chr10:90919623-90919624	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs563732660	chr10:90919646-90919647	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs533163405	chr10:90919684-90919685	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs75060360	chr10:90919689-90919690	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs370136667	chr10:90919760-90919761	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs574559957	chr10:90919791-90919792	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs190543436	chr10:90919863-90919864	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs141554648	chr10:90919878-90919879	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs542119589	chr10:90919978-90919979	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs183570368	chr10:90920120-90920121	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs188217129	chr10:90920129-90920130	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs74536492	chr10:90920133-90920134	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs372186854	chr10:90920135-90920136	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs73366400	chr10:90920160-90920161	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs577705990	chr10:90920181-90920182	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs192792449	chr10:90920219-90920220	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs553831960	chr10:90920289-90920290	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs572057395	chr10:90920307-90920308	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs369594144	chr10:90920321-90920322	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs146262148	chr10:90920352-90920353	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs562218585	chr10:90920395-90920396	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs574178111	chr10:90920445-90920446	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs112058766	chr10:90920448-90920449	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs563086088	chr10:90920453-90920454	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs142603041	chr10:90920475-90920476	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs551438632	chr10:90920477-90920478	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs560148547	chr10:90920517-90920518	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs200335994	chr10:90920538-90920539	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs527644584	chr10:90920539-90920540	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs201202689	chr10:90920552-90920553	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs185364759	chr10:90920634-90920635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs183296342	chr10:90920660-90920661	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs4933495	chr10:90920668-90920669	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs139300674	chr10:90920671-90920672	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs7476906	chr10:90920690-90920691	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs538134809	chr10:90920692-90920693	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Usher syndrome	20538994	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Paraganglioma	17535989	CNVD
Submicroscopic aberration syndrome	21292638	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Colorectal cancer	18645599	CNVD
Polyposis syndrome	18645599	CNVD
Prostate cancer	17245344	CNVD
Glioblastoma multiforme	17369134	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	22032731	CNVD
Ovarian cancer	20844748	CNVD
Glioblastoma multiforme	17002787	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Wilms tumour	21544195	CNVD
Cancer	20164919	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Colorectal cancer	19359472	CNVD
Neurocytoma	17123091	CNVD
Prostate cancer	16461572	CNVD
Basal-like breast cancer	18066063	CNVD
Effusion lymphoma	18079361	CNVD
Lung cancer	21911935	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	22048815	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Glioblastoma multiforme	22291905	CNVD
Glioblastoma multiforme	19435819	CNVD
Glioblastoma multiforme	22286061	CNVD
Intracranial ependymoma	16609018	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Cervical cancer	21062161	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	24453001	CNVD
Breast cancer	16608533	CNVD
Sezary syndrome	18413736	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Type 2 diabetes	21526130	CNVD
Breast cancer	22522925	CNVD
T-cell lymphomas	22341440	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:313 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:90913400-90923000	Weak transcription	NHEK	skin
2	chr10:90913600-90923000	Weak transcription	HMEC	breast
3	chr10:90916000-90921200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr10:90916400-90919600	Enhancers	NHDF-Ad	bronchial
5	chr10:90917200-90920400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr10:90917600-90920200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr10:90917800-90920400	Enhancers	Osteobl	bone
8	chr10:90918200-90919600	Enhancers	Adipose Nuclei	Adipose
9	chr10:90918400-90919400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
10	chr10:90918800-90919600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
11	chr10:90918800-90923000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
12	chr10:90918800-90923200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr10:90919000-90919400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr10:90919000-90923000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
15	chr10:90919400-90920200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
16	chr10:90919400-90925800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
17	chr10:90919600-90920000	Flanking Active TSS	NHDF-Ad	bronchial
18	chr10:90919600-90923000	Weak transcription	Adipose Nuclei	Adipose
19	chr10:90919600-90931400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
20	chr10:90920000-90920600	Enhancers	NHDF-Ad	bronchial
21	chr10:90920200-90920400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr10:90920200-90923200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr10:90920400-90922200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr10:90920400-90923200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
25	chr10:90920400-90923200	Weak transcription	Osteobl	bone
26	chr10:90920600-90923200	Weak transcription	NHDF-Ad	bronchial
27	chr10:90921200-90923000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr10:90922200-90923000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr10:90922200-90923200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr10:90922800-90923000	Enhancers	GM12878-XiMat	blood
31	chr10:90922800-90923200	Enhancers	Monocytes-CD14+_RO01746	blood
32	chr10:90923000-90923200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr10:90923000-90923200	Enhancers	Primary neutrophils fromperipheralblood	blood
34	chr10:90923000-90923200	Enhancers	Primary hematopoietic stem cells short term culture	blood
35	chr10:90923000-90923200	Enhancers	Primary T helper naive cells from peripheral blood	blood
36	chr10:90923000-90923200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr10:90923000-90923200	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
38	chr10:90923000-90923400	Enhancers	Primary B cells from cord blood	blood
39	chr10:90923000-90923400	Enhancers	Primary T helper cells PMA-I stimulated	--
40	chr10:90923000-90923400	Enhancers	Primary T helper cells fromperipheralblood	blood
41	chr10:90923000-90923400	Enhancers	Adipose Nuclei	Adipose
42	chr10:90923000-90923400	Enhancers	Liver	Liver
43	chr10:90923000-90923400	Active TSS	Right Atrium	heart
44	chr10:90923000-90923400	Enhancers	Small Intestine	intestine
45	chr10:90923000-90923400	Enhancers	Thymus	Thymus
46	chr10:90923000-90923400	Enhancers	NHEK	skin
47	chr10:90923000-90923600	Enhancers	Primary B cells from peripheral blood	blood
48	chr10:90923000-90923600	Enhancers	Primary hematopoietic stem cells	blood
49	chr10:90923000-90923600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
50	chr10:90923000-90923600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links